Therefore, in this study, we examined the expression of EBAG9 in human epithelial ovarian cancer using immunohistochemistry, reverse transcription–polymerase chain reaction (RT–PCR) and immunoblotting. Here, EBAG9 is linked to ovarian carcinoma.